MRK

Merck & Co., Inc. (MRK)

NYSE: MRKUSD
119.63 USD
+0.13 (+0.11%)
AT CLOSE (11:59 AM EDT)
119.41
-0.22 (-0.18%)
POST MARKET (AS OF 08:15 PM EDT)
🔴Market: CLOSED
Open?$119.29
High?$121.07
Low?$118.60
Prev. Close?$119.63
Volume?8.3M
Avg. Volume?10.3M
VWAP?$120.17
Rel. Volume?0.81x
Bid / Ask
Bid?$119.26 × 200
Ask?$119.56 × 200
Spread?$0.30
Midpoint?$119.41
Valuation & Ratios
Market Cap?295.8B
Shares Out?2.5B
Float?2.4B
Float %?98.2%
P/E Ratio?16.20
P/B Ratio?5.62
EPS?$7.38
Dividend?2.76%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.54Adequate
Quick Ratio?1.30Adequate
Cash Ratio?0.51Adequate
Debt/Equity?0.94Moderate
ValuationFAIRLY VALUED
Score
78/100
P/E?
16.2CHEAP
P/B?
5.62FAIR
P/S?
4.55FAIR
P/FCF?
23.9FAIR
EV/EBITDA?
11.8CHEAP
EV/Sales?
5.08FAIR
Returns & Efficiency
ROE?
34.7%STRONG
ROA?
13.3%STRONG
Cash Flow & Enterprise
FCF?$12.4B
Enterprise Value?$330.5B
Related Companies
Loading...
News
Profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Employees
75.0K
Market Cap
295.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-20
Address
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Phone: 908-740-4000